{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:18:18Z","timestamp":1791897498278,"version":"4.3.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2014,8,16]],"date-time":"2014-08-16T00:00:00Z","timestamp":1408147200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s40261-014-0218-x","type":"journal-article","created":{"date-parts":[[2014,8,15]],"date-time":"2014-08-15T03:47:05Z","timestamp":1408074425000},"page":"673-679","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Glucose-Lowering Effect of Insulin Degludec is Independent of Subcutaneous Injection Region"],"prefix":"10.1007","volume":"34","author":[{"given":"Leszek","family":"Nosek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Veit","family":"Coester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Roepstorff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik F.","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels R.","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne","family":"Haahr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Heise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,16]]},"reference":[{"key":"218_CR1","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/bmj.327.7411.383","volume":"327","author":"TA Chowdhury","year":"2003","unstructured":"Chowdhury TA, Escudier V. Poor glycaemic control caused by insulin induced lipohypertrophy. BMJ. 2003;327:383\u20134.","journal-title":"BMJ."},{"issue":"12","key":"218_CR2","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/j.1463-1326.2012.01636.x","volume":"14","author":"M Peyrot","year":"2012","unstructured":"Peyrot M, Barnett AH, Meneghini LF, Schumm-Draeger PM. Factors associated with injection omission\/non-adherence in the Global Attitudes of Patients and Physicians in Insulin Therapy study. Diabetes Obes Metab. 2012;14(12):1081\u20137. doi: 10.1111\/j.1463-1326.2012.01636.x .","journal-title":"Diabetes Obes Metab."},{"key":"218_CR3","first-page":"577","volume":"60","author":"MG Minze","year":"2011","unstructured":"Minze MG, Dalal K, Irons BK. Removing barriers to insulin use. J Fam Pract. 2011;60:577\u201380.","journal-title":"J Fam Pract."},{"key":"218_CR4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.7326\/0003-4819-92-1-59","volume":"92","author":"VA Koivisto","year":"1980","unstructured":"Koivisto VA, Felig P. Alterations in insulin absorption and in blood glucose control associated with varying insulin injection sites in diabetic patients. Ann Intern Med. 1980;92:59\u201361.","journal-title":"Ann Intern Med."},{"key":"218_CR5","doi-asserted-by":"crossref","first-page":"366","DOI":"10.2337\/diacare.4.3.366","volume":"4","author":"JA Galloway","year":"1981","unstructured":"Galloway JA, Spradlin CT, Nelson RL, Wentworth SM, Davidson JA, Swarner JL. Factors influencing the absorption, serum insulin concentration, and blood glucose responses after injections of regular insulin and various insulin mixtures. Diabetes Care. 1981;4:366\u201376.","journal-title":"Diabetes Care."},{"key":"218_CR6","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/BF00401147","volume":"36","author":"JE Henriksen","year":"1993","unstructured":"Henriksen JE, Djurhuus MS, Vaag A, Thye-Ronn P, Knudsen D, Hother-Nielsen O, Beck-Nielsen H. Impact of injection sites for soluble insulin on glycaemic control in type 1 (insulin-dependent) diabetic patients treated with a multiple insulin injection regimen. Diabetologia. 1993;36:752\u20138.","journal-title":"Diabetologia."},{"key":"218_CR7","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.2337\/diacare.16.12.1592","volume":"16","author":"JP Bantle","year":"1993","unstructured":"Bantle JP, Neal L, Frankamp LM. Effects of the anatomical region used for insulin injections on glycemia in type I diabetes subjects. Diabetes Care. 1993;16:1592\u20137.","journal-title":"Diabetes Care."},{"key":"218_CR8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF00283747","volume":"22","author":"H S\u00fcsstrunk","year":"1982","unstructured":"S\u00fcsstrunk H, Morell B, Ziegler WH, Froesch ER. Insulin absorption from the abdomen and the thigh in healthy subjects during rest and exercise: blood glucose, plasma insulin, growth hormone, adrenaline and noradrenaline levels. Diabetologia. 1982;22:171\u20134.","journal-title":"Diabetologia."},{"key":"218_CR9","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.2337\/diacare.15.11.1484","volume":"15","author":"JP Vora","year":"1992","unstructured":"Vora JP, Burch A, Peters JR, Owens DR. Relationship between absorption of radiolabeled soluble insulin, subcutaneous blood flow, and anthropometry. Diabetes Care. 1992;15:1484\u201393.","journal-title":"Diabetes Care."},{"key":"218_CR10","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2147\/IJGM.S26889","volume":"4","author":"CM Morello","year":"2011","unstructured":"Morello CM. Pharmacokinetics and pharmacodynamics of insulin analogs in special populations with type 2 diabetes mellitus. Int J Gen Med. 2011;4:827\u201335.","journal-title":"Int J Gen Med."},{"key":"218_CR11","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1007\/s11095-012-0739-z","volume":"29","author":"I Jonassen","year":"2012","unstructured":"Jonassen I, Havelund S, Hoeg-Jensen T, Steensgaard DB, Wahlund PO, Ribel U. Design of the novel protraction mechanism of insulin degludec, an ultra-long-acting basal insulin. Pharm Res. 2012;29:2104\u201314.","journal-title":"Pharm Res."},{"issue":"suppl 1","key":"218_CR12","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1089\/dia.2011.0068","volume":"13","author":"DR Owens","year":"2011","unstructured":"Owens DR. Insulin preparations with prolonged effect. Diabetes Technol Ther. 2011;13(suppl 1):S5\u201314.","journal-title":"Diabetes Technol Ther."},{"key":"218_CR13","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1463-1326.2011.01395.x","volume":"13","author":"M Evans","year":"2011","unstructured":"Evans M, Schumm-Draeger PM, Vora J, King AB. A review of modern insulin analogue pharmacokinetic and pharmacodynamic profiles in type 2 diabetes: improvements and limitations. Diabetes Obes Metab. 2011;13:677\u201384.","journal-title":"Diabetes Obes Metab."},{"key":"218_CR14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1185\/030079902125001416","volume":"19","author":"GU Kuerzel","year":"2003","unstructured":"Kuerzel GU, Shukla U, Scholtz HE, Pretorius SG, Wessels DH, Venter C, Potgieter MA, Lang AM, Koose T, Bernhardt E. Biotransformation of insulin glargine after subcutaneous injection in healthy subjects. Curr Med Res Opin. 2003;19:34\u201340.","journal-title":"Curr Med Res Opin."},{"key":"218_CR15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/protein\/1.3.205","volume":"1","author":"J Markussen","year":"1987","unstructured":"Markussen J, Hougaard P, Ribel U, S\u00f8rensen AR, S\u00f8rensen E. Soluble, prolonged-acting insulin derivatives. I. Degree of protraction and crystallizability of insulins substituted in the termini of the B-chain. Protein Eng. 1987;1:205\u201313.","journal-title":"Protein Eng."},{"key":"218_CR16","first-page":"S426","volume":"54","author":"P Kurtzhals","year":"2011","unstructured":"Kurtzhals P, Heise T, Strauss HM, B\u00f8ttcher SG, Granhall C, Haahr H, Jonassen I. Multi-hexamer formation is the underlying basis for the ultra-long glucose-lowering effect of insulin degludec. Diabetologia. 2011;54:S426.","journal-title":"Diabetologia."},{"key":"218_CR17","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1463-1326.2012.01627.x","volume":"14","author":"T Heise","year":"2012","unstructured":"Heise T, Hermanski L, Nosek L, Feldman A, Rasmussen S, Haahr H. Insulin degludec: four times lower pharmacodynamic variability than insulin glargine under steady-state conditions in type 1 diabetes. Diabetes Obes Metab. 2012;14:859\u201364.","journal-title":"Diabetes Obes Metab."},{"key":"218_CR18","first-page":"S425","volume":"54","author":"T Heise","year":"2011","unstructured":"Heise T, H\u00f6velmann U, Nosek L, B\u00f8ttcher SG, Granhall C, Haahr H. Insulin degludec: twofold longer half-life and a more consistent pharmacokinetic profile than insulin glargine. Diabetologia. 2011;54:S425.","journal-title":"Diabetologia."},{"key":"218_CR19","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1464-5491.1991.tb01631.x","volume":"8","author":"JE Henriksen","year":"1991","unstructured":"Henriksen JE, Vaag A, Hansen IR, Lauritzen M, Djurhuus MS, Beck-Nielsen H. Absorption of NPH (isophane) insulin in resting diabetic patients: evidence for subcutaneous injection in the thigh as the preferred site. Diabet Med. 1991;8:453\u20137.","journal-title":"Diabet Med."},{"key":"218_CR20","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2337\/diacare.23.6.813","volume":"23","author":"DR Owens","year":"2000","unstructured":"Owens DR, Coates PA, Luzio SD, Tinbergen JP, Kurzhals R. Pharmacokinetics of 125I-labeled insulin glargine (HOE 901) in healthy men: comparison with NPH insulin and the influence of different subcutaneous injection sites. Diabetes Care. 2000;23:813\u20139.","journal-title":"Diabetes Care."},{"key":"218_CR21","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/j.1463-1326.2012.01638.x","volume":"14","author":"T Heise","year":"2012","unstructured":"Heise T, Nosek L, B\u00f8ttcher SG, Hastrup H, Haahr H. Ultra-long-acting insulin degludec has a flat and stable glucose-lowering effect in type 2 diabetes. Diabetes Obes Metab. 2012;14:944\u201350.","journal-title":"Diabetes Obes Metab."},{"key":"218_CR22","unstructured":"Committee for Medicinal Products for Human Use. Guideline on the investigation of bioequivalence. European Medicines Agency. 2010. http:\/\/www.emea.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2010\/01\/WC500070039.pdf . Accessed Apr 2014."},{"key":"218_CR23","unstructured":"US Food and Drug Administration. Bioavailability and bioequivalence requirements. 21 CFR 21 Part 320. 2009. http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/cfrsearch.cfm?cfrpart=320 . Accessed Apr 2014."}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-014-0218-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-014-0218-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-014-0218-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T20:17:10Z","timestamp":1565727430000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-014-0218-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,16]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["218"],"URL":"https:\/\/doi.org\/10.1007\/s40261-014-0218-x","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,16]]}}}